Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Polymyositis
- A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
- Add-on Intravenous Immunoglobulins in Early Myositis
- Study of M5049 in DM and PM Participants (NEPTUNIA)
- Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
- Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
- A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
- A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
- A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
- Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis
- Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
- A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
- Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
- Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
- Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
- Efficacy and Tolerability of BAF312 in Patients With Polymyositis
- Dermatomyositis and Polymyositis Registry
- Abatacept Treatment in Polymyositis and Dermatomyositis
- Anakinra in Myositis
- Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
- Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM
- Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
- Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)
- Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
- Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
- Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis
- Methimazole to Treat Polymyositis and Dermatomyositis
- Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies